05:05 AM EDT, 08/08/2025 (MT Newswires) -- Arrowhead Pharmaceuticals ( ARWR ) reported late Thursday a fiscal Q3 loss of $1.26 per diluted share, narrower than a loss of $1.38 a year earlier.

Analysts polled by FactSet expected a $0.95 loss.

Revenue for the quarter ended June 30 was $27.8 million. The company reported no revenue a year earlier.

Analysts polled by FactSet expected $46.8 million.